Cited by 1,028Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychoanalysis and Psychopathology Research

The DOI matches its Crossref record; 300 of the 302 references it cites were found in a registry or an index.

Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

Lorrin M. Koran, Gregory L. Hanna, Eric Hollander, Gerald Nestadt, Helen Blair Simpson·2008·APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches

DOI 10.1176/appi.books.9780890423363.149114

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1176/appi.books.9780890423363.149114

Cites

300 of 300 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898
Untitled work
(1962) · Medical Entomology and Zoology · Cited by 4,856
The Obsessive-Compulsive Inventory: Development and validation of a short version.
Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002) · Psychological Assessment · doi:10.1037/1040-3590.14.4.485 · Cited by 2,959
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
Untitled work
(1993) · PubMed · Cited by 1,900
The measurement of disability
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421
Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study (POTS) Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.292.16.1969 · Cited by 1,107
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Self-citation
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 989
A controlled trial
Kennedy, C. O. (1971) · British Homeopathic journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 976
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C., Hernández–Dı́az, S., Marter, L. J. V., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 877
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 728
Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder
Mataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716
The Brown assessment of beliefs scale: Reliability and validity
Eisen, J. L., Phillips, K. A., Baer, L., Beer, D. A., Atala, K. D., & Rasmussen, S. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.102 · Cited by 705
A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
Skoog, G., & Skoog, I. G. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.121 · Cited by 634
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 566
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle, C. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110037005 · Cited by 555
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542
Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors
Moses‐Kolko, E. L., Bogen, D. L., Perel, J. M., Bregar, A. J., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 532
Untitled work
(2002) · Cited by 522
Symptom presentation and outcome of cognitive-behavioral therapy for obsessive–compulsive disorder
Abramowitz, J. S., Franklin, M. E., Schwartz, S. A., & Furr, J. M. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.6.1049 · Cited by 519
Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Transfer of drugs and other chemicals into human milk
Roberts, R., Blumer, J. L., Gorman, R. L., Lambert, G. H., Rumack, B. H., SNODGRASS, W. T., Bennett, D. R., ', J. C., Petricciani, J. C., Licata, S., et al. (1989) · PEDIATRICS · Cited by 503
Untitled work
(2005) · Oxford University Press eBooks · Cited by 499
Compulsive hoarding: current status of the research
Steketee, G., & Frost, R. (2003) · Clinical Psychology Review · doi:10.1016/j.cpr.2003.08.002 · Cited by 498
Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review
Abramowitz, J. S. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.1.44 · Cited by 490
A randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome
Sofronoff, K., Attwood, T., & Hinton, S. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.00411.x · Cited by 476
A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder
Eddy, K. T., Dutra, L., Bradley, R., & Westen, D. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.08.004 · Cited by 475
Modification of expectations in cases with obsessional rituals
Meyer, V. (1966) · Behaviour Research and Therapy · doi:10.1016/0005-7967(66)90023-4 · Cited by 461
Child Development Following Exposure to Tricyclic Antidepressants or Fluoxetine Throughout Fetal Life: A Prospective, Controlled Study
Nulman, I., ROVET, J. F., Stewart, D. E., Wolpin, J., Pace‐Asciak, P., Shuhaiber, S., & Koren, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1889 · Cited by 440
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427
Suicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424
Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors
Kulin, N. A., Pastuszak, A. L., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M. L., Ormond, K. E., Matsui, D. M., Schechtman, A. S., Cook, L. P., et al. (1998) · JAMA · doi:10.1001/jama.279.8.609 · Cited by 423
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages
Kirchheiner, J., Brøsen, K., Dahl, M., Gram, L. F., Kasper, S. F., Roots, I., Sjöqvist, F., Spina, E., & Brockmöller, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00299.x · Cited by 422
Treatment of obsessive–compulsive disorder: Cognitive behavior therapy vs. exposure and response prevention
Whittal, M. L., Thordarson, D. S., & McLean, P. D. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.11.012 · Cited by 417
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Self-citation
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships
O'Brien, K. M., & Vincent, N. (2003) · Clinical Psychology Review · doi:10.1016/s0272-7358(02)00201-5 · Cited by 409
Fluvoxamine for Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Controlled, Multicenter Trial
Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H.-M., Claghorn, J. L., Gaffney, G., Greist, J. H., Holland, D., McConville, B. J., Pigott, T. A., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00017 · Cited by 398
A Double-blind Comparison of Clomipramine, Desipramine, and Placebo in the Treatment of Autistic Disorder
Gordon, C. T. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180039004 · Cited by 390
Outcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 388
Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
Gunnell, D., Saperia, J., & Ashby, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.385 · Cited by 386
How effective are cognitive and behavioral treatments for obsessive–compulsive disorder? A clinical significance analysis
Fisher, P. L., & Wells, A. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.11.007 · Cited by 377
Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358
Clomipramine Hydrochloride in Childhood and Adolescent Obsessive-Compulsive Disorder—a Multicenter Trial
DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D. P., FONTAINE, R., Greist, J. H., Reichler, R. J., Katz, R. J., & Landau, P. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00008 · Cited by 345
Cerebral glucose metabolism in obsessive-compulsive hoarding
Saxena, S., Brody, A. L., Maidment, K. M., Smith, E. C., Zohrabi, N., Katz, E., Baker, S. K., & Baxter, L. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1038 · Cited by 343
Cognitive versus behavior therapy in the group treatment of obsessive–compulsive disorder
McLean, P. D., Whittal, M. L., Thordarson, D. S., Taylor, S., Söchting, I., Koch, W. J., Paterson, R., & Anderson, K. W. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.2.205 · Cited by 332
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
Weissman, A. M., Levy, B. T., Hartz, A. J., Bentler, S., Donohue, M., Ellingrod, V. L., & Wisner, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1066 · Cited by 327
Problems and considerations in the valid assessment of personality disorders
Perry, J. C. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.12.1645 · Cited by 324
Behavior therapy for obsessive–compulsive disorder guided by a computer or by a clinician compared with relaxation as a control
Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., Mantle, J. M., & Clary, C. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0209 · Cited by 321
Obsessive compulsive spectrum disorder.
McElroy, S. L., Phillips, K. A., & Pe, K. (1994) · PubMed · Cited by 320
Assessing impairment in patients with panic disorder: the Sheehan Disability Scale
Leon, A. C., Shear, M. K., Portera, L., & Klerman, G. L. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788510 · Cited by 319
Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial
GELLER, D. A., HOOG, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., KLUSZYNSKI, S., Jacobson, J. G., & FLUOXETINE PEDIATRIC OCD STUDY TEAM (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00011 · Cited by 317
A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder
Tollefson, G. D. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070051010 · Cited by 314
A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder
McDougle, C. J., Kresch, L. E., Goodman, W. K., NAYLOR, S. T., Volkmar, F. R., Cohen, D. J., & Price, L. H. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.772 · Cited by 314
Obsessive-Compulsive Spectrum Disorders
Hollander, E., & Wong, C. M. (2010) · Phlebolymphology · doi:10.31887/dcns.2010.12.2 · Cited by 313
Self-citation
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
Freeman, M. P., Freeman, S. A., & McElroy, S. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00299-8 · Cited by 307
Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1521 · Cited by 301
The serotonin syndrome and its treatment
Gillman, P. K. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300111 · Cited by 301
Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues
Greenberg, B. D., Price, L. H., Rauch, S. L., Friehs, G., Noren, G., Malone, D., Carpenter, L. L., Rezai, A. R., & Rasmussen, S. A. (2003) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(03)00005-6 · Cited by 300
Sensory Phenomena in Obsessive-Compulsive Disorder and Tourette's Disorder
Miguel, E. C., Rosário-Campos, M. C. D., Prado, H. D. S., Valle, R. D., Rauch, S. L., Coffey, B. J., Baer, L., Savage, C. R., O'Sullivan, R. L., Jenike, M. A., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0213 · Cited by 299
A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder
Cottraux, J., Note, I., Yao, S. N., Lafont, S., Note, B., Mollard, E., Bouvard, M., Sauteraud, A., Bourgeois, M., & Dartigues, J.-F. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056269 · Cited by 298
Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo
Hohagen, F., Winkelmann, G., Rasche-Räuchle, H., Hand, I., König, A., Münchau, N., Hiss, H., Geiger-Kabisch, C., Käppler, C. D. O., Schramm, P. J., et al. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297924 · Cited by 280
A comparison of behavioral group therapy and individual behavior therapy in treating obsessive–compulsive disorder
FALS-STEWART, W., MARKS, A. P., & SCHAFER, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199303000-00007 · Cited by 279 · cited 1×
“The authors’ meta-analysis of combined completer data from their study and three others (Anderson and Rees 2007; Fals-Stewart et al. 1993; Jaurrieta et al. 2008a) also showed no significant difference.”
Background
Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course
Angst, J., Gamma, A., Endrass, J., Goodwin, R. D., Ajdacic‐Gross, V., Eich, D., & Wulf Rössler, A. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0459-4 · Cited by 279
The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis
Abramowitz, J. S., Whiteside, S. P. H., & Deacon, B. J. (2005) · Behavior Therapy · doi:10.1016/s0005-7894(05)80054-1 · Cited by 274
Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions.
Abramowitz, J. S., Foa, E. B., & Franklin, M. E. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.2.394 · Cited by 272
Risk-Benefit Decision Making for Treatment of Depression During Pregnancy
Wisner, K. L., Zarin, D. A., Holmboe, E. S., Appelbaum, P. S., Gelenberg, A. J., Leonard, H. L., & Frank, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1933 · Cited by 265
Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study
Stein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.756 · Cited by 263
Treatment of Social Phobia With Clonazepam and Placebo
DAVIDSON, J. R. T., Potts, N. L. S., RICHICHI, E., Krishnan, R. R., Ford, S. M., Smith, R. D., & Wilson, W. H. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312000-00008 · Cited by 263
Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants
Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Herings, R. M. C., Leufkens, H. G. M., & Egberts, T. C. G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.21.2367 · Cited by 262
Hoarding and Treatment Response in 38 Nondepressed Subjects With Obsessive-Compulsive Disorder
Black, D. W., Monahan, P. O., Gable, J., Blum, N. S., Clancy, G. P., & Baker, P. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0804 · Cited by 260
Cingulotomy for Refractory Obsessive Compulsive Disorder
Jenike, M. A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810300060009 · Cited by 258
Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199808000-00007 · Cited by 250
Comorbidity of Juvenile Obsessive-Compulsive Disorder with Disruptive Behavior Disorders
GELLER, D. A., Biederman, J., GRIFFIN, S., Jones, J. T., & Lefkowitz, T. R. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199612000-00016 · Cited by 249
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors
Denys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder
Ninan, P. T., Koran, L. M., Kiev, A., Davidson, J. R. T., Rasmussen, S. A., Zajecka, J., Robinson, D. G., Crits-Christoph, P. F., Mandel, F. S., & Austin, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0103 · Cited by 246
Self-citation
Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder
Greist, J. H. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160039008 · Cited by 243
Obsessive-compulsive symptoms in pregnancy and the puerperium:
Abramowitz, J. S., Schwartz, S. A., Moore, K. M., & Luenzmann, K. R. (2003) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(02)00206-2 · Cited by 242
Response versus remission in obsessive-compulsive disorder
Simpson, H. B., Huppert, J. D., Petkova, E., Foa, E. B., & Liebowitz, M. R. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0214 · Cited by 241
Self-citation
Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study
Martínez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S. J. W., & Gunnell, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.389 · Cited by 239
Obsessive-Compulsive Hoarding
Saxena, S., Maidment, K. M., Vapnik, T., Golden, G., Rishwain, T., Rosen, R. M., Tarlow, G., & Bystritsky, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0105 · Cited by 238
Personality disorders and normal personality dimensions in obsessive-compulsive disorder
Samuels, J., Nestadt, G., Bienvenu, O. J., Costa, P. T., Riddle, M. A., Liang, K.-Y., Hoehn-Saric, R., Grados, M. A., & Cullen, B. A. M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.5.457 · Cited by 237
Self-citation
Correcting faulty appraisals of obsessional thoughts
Freeston, M. H., Rhéaume, J., & Ladouceur, R. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(95)00076-3 · Cited by 237
Cognitive-behavioral treatment of obsessive thoughts: a controlled study
Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rhéaume, J., Letarte, H., & Bujold, A. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.405 · Cited by 234
Obsessions and compulsions in Asperger syndrome and high-functioning autism
Russell, A., Mataix‐Cols, D., Anson, M., & Murphy, D. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.6.525 · Cited by 233
Capsulotomy for Obsessive-Compulsive Disorder
Rück, C., Karlsson, A., Steele, J. D., Edman, G., Meyerson, B. A., Ericson, K., Nyman, H., Åsberg, M., & Svanborg, P. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.8.914 · Cited by 232
Strategies for managing sexual dysfunction induced by antidepressant medication
Taylor, M. J., Rudkin, L., Bullemor-Day, P., Lubin, J., Chukwujekwu, C., & Hawton, K. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003382.pub3 · Cited by 231
Obsessive-Compulsive Disorder in Pregnancy, the Puerperium, and the Premenstruum
Williams, K. E., & Koran, L. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0709 · Cited by 229
Self-citation
Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies
Einarson, T. R., & Einarson, A. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1084 · Cited by 229
Paroxetine treatment of compulsive hoarding
Saxena, S., Brody, A. L., Maidment, K. M., & Baxter, L. R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.001 · Cited by 223
Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder
Foa, E. B., Abramowitz, J. S., Franklin, M. E., & Kozak, M. J. (1999) · Behavior Therapy · doi:10.1016/s0005-7894(99)80035-5 · Cited by 223
Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study
Ameringen, M. A. V., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., Lavallée, Y.-J., Nandy, S., Pecknold, J. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.275 · Cited by 221
A Placebo-Controlled Trial of Bupropion SR as an Antidote for Selective Serotonin Reuptake Inhibitor–Induced Sexual Dysfunction
Clayton, A. H., Warnock, J. K., Kornstein, S. G., Pinkerton, R., Sheldon-Keller, A., & McGarvey, E. L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0110 · Cited by 221
Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial
Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220
Obsessive–Compulsive Disorder with and without a Chronic Tic Disorder
Holzer, J. C., McDougle, C. J., Boyarsky, B. K., Price, L. H., Goodman, W. K., Baer, L., & Leckman, J. F. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.469 · Cited by 218
Treatment of Antidepressant-Associated Sexual Dysfunction With Sildenafil
Nurnberg, H. G., Hensley, P. L., Gelenberg, A. J., D, M. F. M., Lauriello, J., & Paine, S. (2003) · JAMA · doi:10.1001/jama.289.1.56 · Cited by 214
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209
A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness
D, M. F. M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 209
Female Reproductive Cycle and Obsessive-Compulsive Disorder
Labad, J., Menchón, J. M., Alonso, P., Segalàs, C., Jiménez‐Múrcia, S., & Vallejo, J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0404 · Cited by 204
A Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder
Cottraux, J. A., Mollard, E., Bouvard, M. A., Marks, I. M., SLUYS, M., NURY, A. M., Douge, R., & Cialdella, P. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199001000-00002 · Cited by 201
The Use of Psychotropic Medications During Breast-Feeding
Burt, V. K., Suri, R., Altshuler, L. L., Stowe, Z. N., Hendrick, V. C., & Muntean, E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1001 · Cited by 201
Obsessive-Compulsive Disorder in Patients With First-Episode Schizophrenia
Poyurovsky, M., Fuchs, C., & Weizman, A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1998 · Cited by 199
Risperidone augmentation in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study
Hollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197
Self-citation
Hoarding in Obsessive-Compulsive Disorder
Winsberg, M. E., Cassic, K. S., & Koran, L. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0905 · Cited by 197
Self-citation
Comorbidity of Obsessive-Compulsive Disorder and Depression: Prevalence, Symptom Severity, and Treatment Effect
Overbeek, T., Schruers, K., Vermetten, E., & Griez, E. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1204 · Cited by 196
Clinical characteristics and treatment response in poor and good insight obsessive–compulsive disorder
Kishore, V. R., Samar, R., Reddy, Y. C. J., Chandrasekhar, C. R., & Thennarasu, K. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2003.12.005 · Cited by 194
Genomewide Scan of Hoarding in Sib Pairs in Which Both Sibs Have Gilles de la Tourette Syndrome
Zhang, H., Leckman, J. F., Pauls, D. L., Tsai, C.-P., Kídd, K. K., & Campos, M. R. (2002) · The American Journal of Human Genetics · doi:10.1086/339520 · Cited by 191
Onset of obsessive-compulsive disorder in pregnancy
Neziroglu, F. A., ANEMONE, R., & Yaryura-Tobias, J. A. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.7.947 · Cited by 191
Cognitive–behavioural approach to understanding obsessional thinking
Salkovskis, P. M., Forrester, E., & Richards, C. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297900 · Cited by 191
Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases
Lykouras, L. P., Alevizos, B., Michalopoulou, P. G., & Rabavilas, A. D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00039-3 · Cited by 189
Effect of Axis II Diagnoses on Treatment Outcome With Clomipramine in 55 Patients With Obsessive-Compulsive Disorder
Baer, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110026003 · Cited by 189
The Treatment of Obsessions
Rachman, S. (2003) · Oxford University Press eBooks · doi:10.1093/med:psych/9780198515371.001.0001 · Cited by 188
Effects of comorbid depression on response to treatment for obsessive-compulsive disorder
Abramowitz, J. S., Franklin, M. E., Street, G. P., Kozak, M. J., & Foa, E. B. (2000) · Behavior Therapy · doi:10.1016/s0005-7894(00)80028-3 · Cited by 188
QUALITY OF LIFE IN OBSESSIVE-COMPULSIVE DISORDER
Koran, L. M. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70177-5 · Cited by 186
Self-citation
The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle, C. J., Goodman, W. K., Leckman, J. F., Barr, L. C., Heninger, G. R., & Price, L. H. (1993) · PubMed · Cited by 186
Cognitive Therapy for Obsessive-Compulsive Disorder: A Guide for Professionals
Wilhelm, S., & Steketee, G. S. (2006) · Cited by 186
Review of the efficacy and safety of antidepressants in youth depression
Cheung, A. H., Emslie, G. J., & Mayes, T. L. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01467.x · Cited by 183
GROUP AND INDIVIDUAL TREATMENT OF COMPULSIVE HOARDING: A PILOT STUDY
Steketee, G. S., Frost, R. O., Wincze, J. P., Greene, K., & Douglass, H. M. (2000) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465800003064 · Cited by 183
Cognitive-Behavioral Therapy for Medication Nonresponders With Obsessive-Compulsive Disorder
Tolin, D. F., Maltby, N., Diefenbach, G. J., Hannan, S. E., & Worhunsky, P. D. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0708 · Cited by 182
What do patients do with their obsessive thoughts?
Freeston, M., & Ladouceur, R. (1997) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(96)00094-0 · Cited by 178
Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors
McDougle, C. J., Kresch, L. E., & Posey, D. J. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005551523657 · Cited by 176
Treatment of depression in children and adolescents
Ryan, N. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67321-7 · Cited by 176
Pharmacological treatment of social anxiety disorder: A meta-analysis
Blanco, C., Schneier, F. R., Schmidt, A. B., Blanco-Jerez, C.-R., Marshall, R. D., Sánchez-Lacay, A., & Liebowitz, M. R. (2003) · Depression and Anxiety · doi:10.1002/da.10096 · Cited by 173
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding
Murphy, P. A., Kern, S. E., Stanczyk, F. Z., & Westhoff, C. L. (2005) · Contraception · doi:10.1016/j.contraception.2004.11.004 · Cited by 170
At Issue: Hierarchical Diagnosis in Chronic Schizophrenia: A Clinical Study of Co-occurring Syndromes
Bermanzohn, P. C., Porto, L., Arlow, P. B., Pollack, S. Z., Stronger, R., & Siris, S. G. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033472 · Cited by 170
The overvalued ideas scale: development, reliability and validity in obsessive–compulsive disorder1A preliminary report of this study was presented at the 66th meeting of the Eastern Psychological Association, Boston, MA and the meeting of the World Congress for Behavioral and Cognitive Therapies, Copenhagen, Denmark. Dean McKay is now at Fordham University, Department of Psychology, Bronx, NY. John Todaro is now at University of Florida, Department of Psychology, Gainesville, FL.1
Neziroglu, F. A., McKay, D., Yaryura-Tobias, J. A., Stevens, K. P., & Todaro, J. F. (1999) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(98)00191-0 · Cited by 169
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday
Rothschild, A. J. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1514 · Cited by 168
Use of antidepressants by pregnant women: Evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making
Bonari, L., Koren, G., Einarson, T. R., Jasper, J. D., Taddio, A., & Einarson, A. (2005) · Archives of Women s Mental Health · doi:10.1007/s00737-005-0094-8 · Cited by 168
Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial
Lovell, K., Cox, D., Haddock, G., Jones, C., Raines, D., Garvey, R., Roberts, C., & Hadley, S. (2006) · BMJ · doi:10.1136/bmj.38940.355602.80 · Cited by 162
Post-treatment effects of exposure therapy and clomipramine in obsessive–compulsive disorder
Simpson, H. B., Liebowitz, M. R., Foa, E. B., Kozak, M. J., Schmidt, A. B., Rowan, V., Petkova, E., Kjernisted, K., Huppert, J. D., Franklin, M. E., et al. (2004) · Depression and Anxiety · doi:10.1002/da.20003 · Cited by 161
Self-citation
Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder
LaSalle-Ricci, V. H., Timpano, K. R., Nelson, K. N., Kazuba, D. M., Justement, L., & Murphy, D. L. (2004) · Depression and Anxiety · doi:10.1002/da.20009 · Cited by 159
Cognitive-behavioral group therapy in obsessive–compulsive disorder: a randomized clinical trial
Volpato Cordioli, A., Heldt, E., Braga Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070785 · Cited by 158
Obsessive-compulsive beliefs and treatment outcome
Lelliott, P. T., Noshirvani, H., Başoğlu, M., Marks, I. M., & Monteiro, W. (1988) · Psychological Medicine · doi:10.1017/s0033291700008382 · Cited by 158
Obsessive-Compulsive Disorder in Schizophrenia
Poyurovsky, M., Weizman, A., & Weizman, R. (2004) · CNS Drugs · doi:10.2165/00023210-200418140-00004 · Cited by 157
Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine
Hollander, E., Allen, A., Steiner, M., Wheadon, D. E., Oakes, R., Burnham, D. B., & Paroxetine OCD Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0919 · Cited by 156
Self-citation
Impact of Age at Onset and Duration of Illness on the Expression of Comorbidities in Obsessive-Compulsive Disorder
Diniz, J. B., do Rosário, M. C., Shavitt, R. G., Cúri, M., Hounie, A. G., Brotto, S. A., & Miguel, E. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0104 · Cited by 156
Insight and treatment outcome in obsessive-compulsive disorder
Eisen, J. L., Rasmussen, S. A., Phillips, K. A., Price, L. H., Davidson, J. R. T., Lydiard, R. B., Ninan, P. T., & Pigott, T. A. (2001) · Comprehensive Psychiatry · doi:10.1053/comp.2001.27898 · Cited by 152
Involving Family Members in the Treatment of OCD
Renshaw, K. D., Steketee, G. S., & Chambless, D. L. (2005) · Cognitive Behaviour Therapy · doi:10.1080/16506070510043732 · Cited by 151
A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder
Denys, D., van der Wee, N., van Megen, H. J. G. M., & Westenberg, H. G. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095342.32154.54 · Cited by 151
Untitled work
(2005) · Cited by 151
Treatment of depressive and obsessive‐compulsive symptoms in OCD by imipramine and behaviour therapy
Foa, E. B., Kozak, M. J., Steketee, G. S., & McCarthy, P. R. (1992) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1992.tb00995.x · Cited by 150
Relapse prevention program for treatment of obsessive-compulsive disorder.
Hiss, H., Foa, E. B., & Kozak, M. J. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.4.801 · Cited by 146
ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth
Mann, J. J., Emslie, G. J., Baldessarini, R. J., Beardslee, W. R., FAWCETT, J. A., Goodwin, F. K., Leon, A. C., Meltzer, H. Y., Ryan, N. D., Shaffer, D., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300958 · Cited by 144
A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder
Denys, D. A. J. P., van Megen, H. J. G. M., van der Wee, N. J. A., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0106 · Cited by 144
Differential response of seven subjects with autistic disorder to clomipramine and desipramine
Gordon, C. T., Rapoport, J. L., Hamburger, S. D., State, R. C., & Mannheim, G. B. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.3.363 · Cited by 142
Obsessive–compulsive behaviors in parents of multiplex autism families
Hollander, E., King, A., Delaney, K., Smith, C. J., & Silverman, J. M. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(02)00304-9 · Cited by 142
Self-citation
An Overview of Psychotropic Drug-Drug Interactions
Sandson, N. B., Armstrong, S. C., & Cozza, K. L. (2005) · Psychosomatics · doi:10.1176/appi.psy.46.5.464 · Cited by 142
Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
Perugi, G., Toni, C., Frare, F., Travierso, M. C., Hantouche, E. G., & Akiskal, H. S. (2002) · PubMed · Cited by 142
Obsessive-compulsive syndromes and disorders
Angst, J., Gamma, A., Endrass, J., Hantouche, E. G., Goodwin, R., Ajdacic‐Gross, V., Eich, D., & Wulf Rössler, A. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0576-8 · Cited by 142
Does cognitive-behavioral therapy cure obsessive–compulsive disorder? A meta-analytic evaluation of clinical significance
Abramowitz, J. S. (1998) · Behavior Therapy · doi:10.1016/s0005-7894(98)80012-9 · Cited by 141
Drug interactions with newer antidepressants: role of human cytochromes P450.
Greenblatt, D. J., Moltke, L. L., Harmatz, J. S., & Shader, R. I. (1998) · PubMed · Cited by 141
Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive Disorder
Koran, L. M., Hackett, E., Rubin, A., Wolkow, R., & Robinson, D. G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.88 · Cited by 140
Self-citation
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study
Erzegovesi, S., Guglielmo, E., Siliprandi, F., & Bellodi, L. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.04.004 · Cited by 136
Predictors of Treatment Outcome in the Behavioural Treatment of Obsessive-Compulsive Disorder
Keijsers, G. P. J., Hoogduin, C. A. L., & Schaap, C. P. D. R. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.165.6.781 · Cited by 136
CLINICAL USE OF RATING SCALES IN DIAGNOSIS AND TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Conners, C. K. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70159-0 · Cited by 135
The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization
Fireman, B., Koran, L. M., Leventhal, J. L., & Jacobson, A. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1904 · Cited by 135
Self-citation
Gender Differences in Depression and Antidepressant Pharmacokinetics and Adverse Events
Frackiewicz, E. J., Sramek, J. J., & Cutler, N. R. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.18465 · Cited by 135
Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder
Koran, L. M., Aboujaoude, E. N., Bullock, K. D., Franz, B., Gamel, N. N., & Elliott, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0312 · Cited by 132
Self-citation
Tic or Compulsion?
Mansueto, C. S., & Keuler, D. J. (2005) · Behavior Modification · doi:10.1177/0145445505279261 · Cited by 132
Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome
Sivojelezova, A., Shuhaiber, S., Sarkissian, L., Einarson, A., & Koren, G. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.05.012 · Cited by 128
Obsessive-compulsive disorder among patients with anorexia nervosa and bulimia nervosa
Thiel, A., Broocks, A., Ohlmeier, M. D., Jacoby, G. E., & Schüßler, G. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.72 · Cited by 127
Pharmacokinetic Drug Interactions of New Antidepressants: A Review of the Effects on the Metabolism of Other Drugs
Richelson, E. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.9.835 · Cited by 127
Autistic traits in obsessive-compulsive disorder
Bejerot, S. (2001) · Nordic Journal of Psychiatry · doi:10.1080/08039480152036047 · Cited by 126
Refractory obsessive-compulsive disorder: state-of-the-art treatment.
Hollander, E., Bienstock, C. A., Koran, L. M., Pallanti, S., Marazziti, D., Rasmussen, S. A., Ravizza, L., Benkelfat, C., Saxena, S., Greenberg, B. D., et al. (2002) · PubMed · Cited by 119
Self-citation
Response Acceleration With Mirtazapine Augmentation of Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid Depression
Pallanti, S., Quercioli, L., & Bruscoli, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1015 · Cited by 118
The World of the Autistic Child: Understanding and Treating Autistic Spectrum Disorders
(1999) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.153.6.659 · Cited by 118
Schizotypal personality disorder:
Minichiello, W. E., Baer, L., & Jenike, M. A. (1987) · Journal of Anxiety Disorders · doi:10.1016/0887-6185(87)90032-6 · Cited by 117
Cognitive-Behavioral Psychotherapy for Pediatric Obsessive-Compulsive Disorder
March, J. S., Franklin, M. E., Nelson, A., & Foa, E. B. (2001) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3001_3 · Cited by 117
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial
Dannon, P. N., Sasson, Y., Hirschmann, S., Iancu, I., Grunhaus, L. J., & Zohar, J. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00065-1 · Cited by 116
Group and multifamily behavioral treatment for obsessive compulsive disorder: A pilot study
Noppen, B. L. V., Steketee, G. S., McCorkle, B. H., & Pato, M. T. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00021-2 · Cited by 115
Effects of Third Trimester Fluoxetine Exposure on the Newborn
GOLDSTEIN, D. J. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199512000-00005 · Cited by 114
Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD?
Abramowitz, J. S., & Foa, E. B. (2000) · Behavior Therapy · doi:10.1016/s0005-7894(00)80045-3 · Cited by 111
Aging and Clinical Pharmacology: Implications for Antidepressants
Lotrich, F. E., & Pollock, B. G. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005280297 · Cited by 110
Cognitive Therapy of Obsessive – compulsive Disorder: Treating Treatment Failures
Salkovskis, P. M., & Warwick, H. M. C. (1985) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s0141347300011095 · Cited by 109
A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder
Liebowitz, M. R., Mangano, R. M., Bradwejn, J., & Asnis, G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0213 · Cited by 107
A comparative study of family-based and patient-based behavioural management in obsessive–compulsive disorder
Mehta, M. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.1.133 · Cited by 104
Long-Term Treatment of Obsessive-Compulsive Disorder After an Acute Response: A Comparison of Fluoxetine Versus Placebo
Romano, S. J., Goodman, W. K., Tamura, R., & Gonzales, J. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00009 · Cited by 98
Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany
Grabe, H. J., Meyer, C., Hapke, U., Rumpf, H., Freyberger, H. J., Dilling, H., & John, U. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170047 · Cited by 96
Selective serotonin re-uptake inhibitors and the risk of bleeding
Weinrieb, R. M., Auriacombe, M., Lynch, K. G., & Lewis, J. D. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.2.337 · Cited by 96
Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder
Simpson, H. B., Gorfinkle, K., & Liebowitz, M. R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0904 · Cited by 96
Self-citation
Adding cognitive therapy elements to exposure therapy for obsessive compulsive disorder: a controlled study
Vogel, P. A., Stiles, T. C., & Götestam, K. G. (2004) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465804001353 · Cited by 94
Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults
McCann, B. S., & Roy‐Byrne, P. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2004.02.006 · Cited by 93
Quality-of-Life Changes Among Patients With Obsessive-Compulsive Disorder in a Partial Hospitalization Program
Bystritsky, A., Saxena, S., Maidment, K. M., Vapnik, T., Tarlow, G., & Rosen, R. M. (1999) · Psychiatric Services · doi:10.1176/ps.50.3.412 · Cited by 93
A Parent's Guide to Asperger Syndrome and High-Functioning Autism: How to Meet the Challenges and Help Your Child Thrive
Ozonoff, S. J., Dawson, G., & McPartland, J. C. (2002) · Medical Entomology and Zoology · Cited by 92
Neuropsychologic assessment of patients for movement disorder surgery
Saint‐Cyr, J. A., & Tr�panier, L. L. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5 · Cited by 92
A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder.
Rubenstein, C., Pigott, T. A., L'Heureux, F., Hill, J., & Murphy, D. L. (1992) · PubMed · Cited by 91
The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk
Stowe, Z. N., Hostetter, A. L., Owens, M. J., Ritchie, J., Sternberg, K., Cohen, L. S., & Nemeroff, C. B. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0114 · Cited by 91
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Koran, L. M., Gamel, N. N., Choung, H. W., Smith, E. H., & Aboujaoude, E. N. (2005) · PubMed · Cited by 91
Self-citation
D-Amphetamine in obsessive-compulsive disorder
Insel, T. R., Hamilton, J. A., Guttmacher, L. B., & Murphy, D. L. (1983) · Psychopharmacology · doi:10.1007/bf00436159 · Cited by 90
Correction of inflated responsibility in the treatment of obsessive-compulsive disorder
Ladouceur, R., Léger, É., Rhéaume, J., & Dubé, D. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(96)00042-3 · Cited by 90
Untitled work
(1996) · PubMed · Cited by 90
Are Antidepressants Associated With New-Onset Suicidality in Bipolar Disorder?
Bauer, M. S., Wisniewski, S. R., Marangell, L. B., Chessick, C. A., Allen, M. H., Dennehy, E. B., Miklowitz, D. J., Thase, M. E., Sachs, G. S., & STEP-BD Investigators (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0108 · Cited by 89

Sorted by citations

Depression in Older Adults
Fiske, A., Wetherell, J. L., & Gatz, M. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153621 · Cited by 2,353
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Clinical experience suggests that some patients may benefit from adjunctive clomipramine; however, plasma levels should be monitored because of the risk of drug interactions with SSRIs [747,813].”
BackgroundInfluential
Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry
Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S., & Ersche, K. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.009 · Cited by 1,003
Obsessive-compulsive disorder
Abramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002

See all 1,028

Authors: Koran, L. M., Hanna, G. L., Hollander, E., Nestadt, G., & Simpson, H. B.
ORCID: Lorrin M. Koran
Gregory L. Hanna
Eric Hollander
Gerald Nestadt
Helen Blair Simpson
Venue: APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches
Publisher: American Psychiatric Association
Published: 2008-01-17
Volume: 164
Issue: 12 Suppl
Pages: 5-53
DOI: 10.1176/appi.books.9780890423363.149114
OpenAlex: W306343222
Cited by: 1,028
References: 302
Citations by year: 2026: 1 · 2025: 36 · 2024: 52 · 2023: 54 · 2022: 53 · 2021: 73 · 2020: 50 · 2019: 57 · 2018: 52 · 2017: 57 · 2016: 67 · 2015: 79 · 2014: 76 · 2013: 70 · 2012: 66
FWCI: 265.99
Type: book chapter
Language: en
Open access: closed
Locations: American Psychiatric Association Publishing eBooks (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords: obsessive-compulsive disorder, treatment, psychotherapy, pharmacotherapy, cognitive behavioral therapy, selective serotonin reuptake inhibitors
MeSH terms: Adolescent, Adult, Age Factors, Child, Combined Modality Therapy, Female, Humans, Male, Obsessive-Compulsive Disorder, Patient Care Planning, Patient Compliance, Pregnancy, Psychiatric Status Rating Scales, Psychotherapy, Severity of Illness Index, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks